Skip to main content
Advanced Science logoLink to Advanced Science
. 2024 Feb 26;11(17):2309624. doi: 10.1002/advs.202309624

Treatment of Acute Wound Infections by Degradable Polymer Nanoparticle with a Synergistic Photothermal and Chemodynamic Strategy

Fangzhou Chen 1,2, Lin Liu 3, Dongsheng Tang 4, Hanchen Zhang 4, Nier Wu 2, Lin Wang 2, Hongbo Li 3,✉, Haihua Xiao 4,✉, Dongsheng Zhou 2,✉
PMCID: PMC11077640  PMID: 38408124

Abstract

Mild‐heat photothermal antibacterial therapy avoids heat‐induced damage to normal tissues but causes bacterial tolerance. The use of photothermal therapy in synergy with chemodynamic therapy is expected to address this issue. Herein, two pseudo‐conjugated polymers PM123 with photothermal units and PFc with ferrocene (Fc) units are designed to co‐assemble with DSPE‐mPEG2000 into nanoparticle NPM123/Fc. NPM123/Fc under 1064 nm laser irradiation (NPM123/Fc+NIR‐II) generates mild heat and additionally more toxic ∙OH from endogenous H2O2, displaying a strong synergistic photothermal and chemodynamic effect. NPM123/Fc+NIR‐II gives >90% inhibition rates against MDR ESKAPE pathogens in vitro. Metabolomics analysis unveils that NPM123/Fc+NIR‐II induces bacterial metabolic dysregulation including inhibited nucleic acid synthesis, disordered energy metabolism, enhanced oxidative stress, and elevated DNA damage. Further, NPM123/Fc+NIR‐II possesses >90% bacteriostatic rates at infected wounds in mice, resulting in almost full recovery of infected wounds. Immunodetection and transcriptomics assays disclose that the therapeutic effect is mainly dependent on the inhibition of inflammatory reactions and the promotion of wound healing. What is more, thioketal bonds in NPM123/Fc are susceptible to ROS, making it degradable with highly favorable biosafety in vitro and in vivo. NPM123/Fc+NIR‐II with a unique synergistic antibacterial strategy would be much less prone to select bacterial resistance and represent a promising antibiotics‐alternative anti‐infective measure.

Keywords: acute wound infections, biodegradable polymer, chemodynamic therapy, ESKAPE pathogens, photothermal therapy


NPM123/Fc under 1064 nm laser irradiation (NPM123/Fc+NIR‐II) generates mild heat and additionally more toxic ∙OH from endogenous H2O2, displaying a synergistic effect of PTT and CDT for anti‐infection. Thioketal bonds in NPM123/Fc are susceptible to ROS, making it degradable with highly favorable biosafety. NPM123/Fc+NIR‐II representes a biocompatible and broad‐spectrum nanoplatform for antibiotics‐alternative treatment of superficial infections.

graphic file with name ADVS-11-2309624-g004.jpg

1. Introduction

With the wide use and abuse of antibiotics to prevent and treat bacterial infections, antibiotic resistance is occurring increasingly. Particularly, ESKAPE pathogens including Enterococcus faecium (Ec. faecium), Staphylococcus aureus (S. aureus), Klebsiella pneumoniae (K. pneumoniae), Acinetobacter baumannii (A. baumannii), Pseudomonas aeruginosa (P. aeruginosa), and Enterobacter species (especially Eb. cloacae and Eb. hormaechei) are commonly characteristic of multidrug resistance (MDR), and they represent the leading cause of refractor infections in hospital settings throughout the world, leading to higher medical costs, prolonged hospital stays, and increased mortality.[ 1 ]

Contemporary antibiotics‐alternative therapeutic strategies such as nanotechnology are potential options for combating MDR bacteria including ESKAPE pathogens.[ 2 ] Various organic or inorganic nanomaterials have the ability to evade existing mechanisms of acquired drug resistance, taking advantages such as bare selection for resistance, minimal invasion, and low host toxicity.[ 3 ] In addition, the unique physico–chemical properties (such as size, shape, and surface chemistry) of nanomaterials render the elevated targeting attack pathogens.[ 3 ] Currently, nanotechnology‐based antibacterial agents mainly rely on four major principles of action, namely sonodynamic therapy (SDT), photodynamic therapy (PDT), chemodynamic therapy (CDT), and photothermal therapy (PTT). SDT utilizes senosensitizers to produce reactive oxygen species (ROS) from surrounding oxygen under low‐intensity ultrasound, killing bacteria through the synergistic action of ROS and ultrasound.[ 4 ] Likewise, PDT employs photosensitizers that can transfer photon energy to surrounding oxygen to produce ROS.[ 5 ]

PTT makes use of photothermal agents to absorb energy from the near‐infrared region I and II (NIR‐I and NIR‐II) light for the production of heat.[ 6 , 7 , 8 ] However, a high local temperature of up to 70 °C is required to kill bacteria completely if PTT is used alone.[ 9 ] This will bring pain to the patients and even damage to surrounding tissues.[ 9 ] On the contrary, the use of mild heat (commonly ≤ 48 °C in vivo) in PTT can avoid heat‐induced damage of normal tissues,[ 10 ] but mild heat will lead to bacterial tolerance due to inducible expression of heat shock proteins.[ 11 ] Combining PTT with another different strategy (e.g., CDT,[ 12 ] PDT,[ 13 ] or quaternary phosphonium[ 14 ]) could address the above issues and, in this case, CDT‐generated hydroxyl radicals (∙OH), PDT‐generated ROS or cationic quaternary phosphonium agent acts as a synergistic factor of PTT‐generated mild heat, endowing improved broad‐spectrum antibacterial effects.

CDT is applied to convert hydrogen peroxide (H2O2) into more toxic ∙OH via a Fenton or Fenton‐like reaction.[ 15 ] In this context, Ferrocene (Fc) has attracted the interest in developing nanomaterials to convert endogenous abundant H2O2 at infection sites to participate in Fenton‐like reaction, where H2O2 oxidizes Fc into ferrocenium (Fce) and meanwhile itself is catalyzed into ∙OH.[ 16 , 17 , 18 ]

Herein, we developed two biodegradable polymers namely PM123 and PFc, which were assembled with commercial DSPE‐mPEG2000 to generate the nanoparticle NPM123/Fc (Scheme 1 ). PM123 contained the NIR‐II polymer photothermal agent M123 plus the ROS‐sensitive thioketal bonds, while PFc harbored Fc as well as the thioketal bonds. NPM123/Fc under 1064 nm laser irradiation (NPM123/Fc+NIR‐II) exhibited M123‐mediated photothermal activity and Fc‐dependent chemodynamic effect, which worked in a synergistic manner. NPM123/Fc+NIR‐II was highly efficient in inhibiting MDR ESKAPE pathogens in vitro and in treating infected wounds in a mouse model. NPM123/Fc was degradable upon ROS, and it would be highly degradable, rapidly cleared, and hypotoxic in the body. NPM123/Fc+NIR‐II with a unique two‐way synergistic antibacterial strategy would be much less prone to select bacterial resistance and represented a promising measure for antibiotics‐alternative therapy.

Scheme 1.

Scheme 1

Schematic illustration of development of NPM123/Fc for treatment of acute wound infections. a) The polymer PM123 was synthesized from the four monomers namely M1, M2, M3, and M4, among which M1, M2, M3 constituted the photothermal agent M123 while M4 contained the ROS‐sensitive thioketal bond. b) The polymer PFc was synthesized from another four monomers namely M5 (Fc), M6 (containing thioketal bond), M7, and M8 (mPEG). c) PM123, PFc, and DSPE‐mPEG2000 were self‐assembled together into nanoparticle NPM123/Fc. d) NPM123/Fc under 1064 nm laser irradiation (NPM123/Fc+NIR‐II) generates mild heat and additionally more toxic ∙OH from endogenous H2O2, displaying a synergistic effect of PTT and CDT for anti‐infection. The thioketal bonds in NPM123/Fc are susceptible to ROS, making it degradable with highly favorable biosafety in vitro and in vivo. NPM123/Fc+NIR‐II represented a biocompatible and broad‐spectrum nanoplatform for antibiotics‐alternative treatment of superficial infections.

2. Results and Discussion

2.1. Preparation and Characterization of Polymers and Nanoparticles

The present study involved three different polymers (i.e., PM123, PFc, and DSPE‐mPEG2000) and three distinct nanoparticles (i.e., NPM123, NPFc, and NPM123/Fc) as shown in Scheme 1 and Scheme S1 (Supporting Information). PM123 (Scheme 1a) was synthesized from the four monomers namely M1, M2, M3, and M4. M1 was the linker responsible for linking M2, M3 and M4 to form PM123. M2 mainly endowed PM123 with photothermal properties. M3 caused the UV absorption wavelength of PM123 to be redshifted and thus made PM123 excitable at 1064 nm. The M123 moiety as a whole could be recognized as a polymer photothermal agent. M4 contained the ROS‐sensitive thioketal bond, conferring the degradability of PM123. PFc (Scheme 1b) was synthesized from another four monomers namely M5, M6, M7, and M8. M5 was Fc. M6 was the linker responsible for linking M5, M7, and M8 to form PFc. M7 contained the ROS‐sensitive thioketal bond, conferring the degradability to PFc. Since M5, M6, and M7 were all hydrophobic, M8 (mPEG) was added to render the amphipathicity of PFc. The successful synthesis of PM123 (Figure S1, Supporting Information) or PFc (Figure S2, Supporting Information) was validated by 1H NMR (nuclear magnetic resonance) spectra. For PM123, the peaks at 0.5 to 2 ppm could be attributed to the alkane chain, the peaks at 7 to 9.5 ppm could be attributed to the hydrogen of thiophene, and the peaks at 2.5 to 4.5 ppm could be attributed to the methylene group of ROS‐sensitive thioketal bond (Figure S1, Supporting Information). For PFc, the peaks at 7 to 8 ppm belonged to Fc and the peak at 1.5 ppm belonged to the methyl of thioketal bond (Figure S2, Supporting Information), indicating that PFc contained Fc and ROS‐sensitive moieties. Hydrophobic PM123 or amphipathic PFc was subsequently self‐assembled with amphipathic DSPE‐mPEG2000, generating NPM123 or NPFc, respectively (Scheme S1, Supporting Information). PM123, PFc, and DSPE‐mPEG2000 were self‐assembled together into NPM123/Fc (Scheme 1c).

As determined by transmission electron microscopy (TEM) and scanning electron microscopy (SEM), NPM123, NPFc, and NPM123/Fc displayed uniform spherical morphology with average diameters at about 106, 108, and 120 nm, respectively (Figure  1a; Figures S3 and S4, Supporting Information). Energy dispersive X‐ray spectral scanning (EDXS) showed that there were the key elements C, N, O, Fe and S in NPM123/Fc (Figure 1b), and the presence of Fe confirmed the successful doping of Fc into NPM123/Fc.

Figure 1.

Figure 1

Characterization of NPM123/Fc. a) TEM images of NPM123/Fc. Scale bar is 100 nm. b) STEM and EDXS images of NPM123/Fc. Scale bar is 200 nm. c) UV–vis–NIR absorption spectra of NPM123, NPFc, and NPM123/Fc. d) Time–concentration–temperature curves of NPM123/Fc under 1064 nm laser irradiation (1.0 W cm−2, 5 min). e) Time‐dependent heating and cooling curve of 100 µg mL−1 NPM123/Fc under 1064 nm laser irradiation (1.0 W cm−2, 11 min). The 𝜂 value was calculated, through linear regression, from this heating and cooling curve. f) Time–temperature curve of four cycles of heating and cooling of NPM123/Fc under 1064 nm laser irradiation (1.0 W cm−2, 5 min). g) Absorption curves of MB as a selective trapping agent to detect ∙OH in the reaction mixture of NPM123/Fc+H2O2 or NPM123+H2O2 after different incubation times. h) Trends of UV absorption at 410 nm as indicated by the above MB‐based detection results. DLS detection of i) diameter sizes, j) PDIs, and k) average Zeta potentials of NPM123/Fc in the presence and absence of H2O2. l) Schematic illustration of H2O2‐mediated degradability, M123‐dependent NIR‐II photothermal activity, and Fc‐dependent chemodynamic activity of NPM123/Fc in vitro.

UV–vis–NIR absorption spectra denoted that each of NPM123 and NPM123/Fc had two major absorption peaks at 740 and 1064 nm, indicating that these nanoparticles had absorption extended in NIR‐II (Figure 1c). In order to investigate the photothermal properties, NPM123 or NPM123/Fc at 0 to 200 µg mL−1 in the aqueous solution was irradiated with a 1064 nm laser at 1 W cm−2 for 5 min, and the time‐temperature curves were recorded (Figure 1d; Figure S5, Supporting Information). The heating process became faster with the increasing of NPM123/Fc concentrations, and 100 µg mL−1 NPM123/Fc (used for the following in vitro and in vivo antibacterial assays) gave a temperature increase to 50 °C under laser irradiation for 3 min (Figure 1d; Figure S5, Supporting Information). NPM123 showed similar results (Figure S6, Supporting Information). The photothermal conversion efficiency (𝜂) of NPM123 and NPM123/Fc were calculated as 38.16% and 37.8% respectively (Figure 1e; Figure S7, Supporting Information), which were comparable to the majority of reported polymer‐based NIR‐II photothermal nanomaterials.[ 19 , 20 ] After four cycles of heating (irradiation) and cooling, 100 µg mL−1 NPM123/Fc gave the nearly same temperature elevation to about 60 °C in each cycle and the almost constant cooling rates at about 3.2 °C min−1 for all cycles (Figure 1f). NPM123 showed similar results (Figure S8, Supporting Information). Therefore, NPM123/Fc containing the photothermal agent M123 had an efficient and stable NIR‐II photothermal effect in vitro upon 1064 nm laser irradiation.

Given the participation of Fc and H2O2 in a Fenton‐like reaction,[ 16 , 17 , 18 ] 100 µg mL−1 NPM123 or NPM123/Fc was mixed with 1 mm H2O2 and 2 mm 1,3‐diphenylisobenzofuran (DPBF), followed by incubation for 0–3.5 min, to test consumption of H2O2 (Figures S9 and S10, Supporting Information). DPBF with an absorption peak at 410 nm was used herein as a selective trapping agent of ROS including H2O2 and ∙OH.[ 21 ] With the prolonging of incubation times, the absorption peaks as detected by SpectraMax Microplate Reader were decreased for NPM123/Fc, NPM123 and NPFc (Figure S9, Supporting Information), but the absorbance of NPM123/Fc or NPFc at 410 nm decreased faster than that of NPM123 (Figure S10, Supporting Information); therefore, both NPM123/Fc and NPFc (but not NPM123) would produce other ROS from H2O2, and Fc played a role in ROS production in NPM123/Fc. To test the production of ∙OH from H2O2, the ∙OH‐specific trapping agent methylene blue (MB) was used to determine its absorption peak at 664 nm; with the prolonging of incubation times, NPM123/Fc or NPFc gave rapidly decreased absorption peaks, but NPM123 gave almost unchanged absorption peaks (Figure 1g; Figure S11, Supporting Information). Moreover, the absorbance of NPM123/Fc or NPFc at 664 nm decreased faster than that of NPM123 (Figure 1h; Figure S11, Supporting Information). These results indicated that NPM123/Fc or NPFc (but not NPM123) produced ∙OH from H2O2, which was dependent on Fc. The Fc release kinetics of NPM123/Fc in vitro was measured by ICP‐MS‐based detection of dissociated Fc; as shown in Figure S12 (Supporting Information), there was a gradual increase in Fc release from 0 to 48 h whether there was the presence of 10 mm H2O2 or not, but the detected Fc release rate 76.48% in the presence of 10 mm H2O2 at 48 h was much higher the counterpart value (23.31%) in the presence of PBS. Therefore, Fc could be effectively released from NPM123/Fc in the presence of H2O2. To test the oxidation of Fc, 1 mg mL−1 PFc was incubated with 1 mm H2O2 at 37 °C for 24 h, and then X‐ray photoelectron spectroscopy (XPS) revealed that the addition of H2O2 made the change of iron valence state from +2 into +3 (Figure S13, Supporting Information). Therefore, NPM123/Fc had the chemodynamic effect in vitro to produce ∙OH from H2O2 and meanwhile to oxidize Fc into Fce.

To test sensitivity to H2O2 in vitro, NPM123, NPFc, and NPM123/Fc were incubated with 1 mm H2O2 for 3.5 min. TEM and SEM disclosed nearly complete disintegration of nanoparticles (Figures S14 and S15, Supporting Information). As determined by dynamic light scattering (DLS), the average diameter sizes (Figure 1i) and the polydispersity indexes (PDIs, Figure 1j) of NPM123/Fc were changed from 123.07 to 2531.33 nm (giving a huge fold increase of 20.57) and from 0.16 to 0.93 (approaching nearly 1[ 22 ]), respectively, and moreover the average Zeta potentials of NPM123/Fc were changed from −31.08 mV to + 7.22 mV (Figure 1k). In addition, NPM123 and NPFc gave similar DLS‐detected results (Figure S16, Supporting Information). Therefore, the ROS‐sensitive thioketal bonds in NPM123, NPFc, and NPM123/Fc were degradable upon H2O2 in vitro and then these nanoparticles were disintegrated in the solutions; as the degradation of NPFc or NPM123/Fc, Fc was released in the solution and then oxidized by H2O2 into positively charged Fce, thereby causing the change in overall Zeta potentials from negative charge into positive. In addition, the degradation of NPM123 or NPM123/Fc was along with the release of photothermal agent M123.

Taken together, as determined by comprehensive in vitro characterizations, NPM123/Fc was degradable upon H2O2 and, moreover, it exhibited the photothermal activity to produce mild heat from NIR‐II laser energy and also the Fc‐dependent chemodynamic activity to produce ∙OH from H2O2 (Figure 1l).

2.2. Antibacterial Efficacy Against ESKAPE Pathogens In Vitro

The in vitro antibacterial efficacies of NPM123, NPFc, and NPM123/Fc were measured by using plate counting method with clinical MDR ESKAPE isolates as model pathogens, and a total of eight treatment groups namely FF1 (Mock), FF2 (NIR‐II), FF3 (NPM123), FF4 (NPM123+NIR‐II), FF5 (NPFc), FF6 (NPFc+NIR‐II), and FF7 (NPM123/Fc), and FF8 (NPM123/Fc+NIR‐II) was set (Figure  2 ). 1 mm H2O2 was added for all in vitro antibacterial experiments, which was needed to degrade NPM123, NPFc, and NPM123/Fc to release M123 or/and Fc for subsequent bactericidal actions. No significant inhibition effects on all six ESKAPE bacteria (Figure 2a–f) were found for the five scheduled control groups FF1, FF2, FF3, FF5, and FF7, confirming that each nanoparticle along with 1 mm exogenous H2O2 had very limited bactericidal activity in the absence of laser irradiation. FF4 (PTT alone) had a higher bactericidal activity relative to FF6 (CDT alone); notably, when PTT and CDT worked together (FF8), the highest antibacterial efficacy against both Gram‐positive (Figure 2a,b) and Gram‐negative (Figure 2c–f) ESKAPE bacteria were detected with inhibition rates at 97.79%, 91.42%, 92.82%, 97.6%, 94.54%, and 93.53% for Ec. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and Eb. hormaechei, respectively.

Figure 2.

Figure 2

Antibacterial efficacy against ESKAPE pathogens in vitro. FF1: Mock, FF2: NIR‐II, FF3: NPM123, FF4: NPM123+NIR‐II, FF5: NPFc, FF6: NPFc+NIR‐II, FF7: NPM123/Fc, FF8: NPM123/Fc+NIR‐II. NIR‐II represents 1064 nm laser irradiation (1.0 W cm−2, 3.5 min). a–f) Representative photos of plate count agars for ESKAPE pathogens post treatment, and corresponding statistical analysis of bacterial counts. Data are presented as mean ± SD (n = 6). ns: p ≥ 0.05, *: p < 0.05, **: p < 0.01, ***: p < 0.001. g) Representative CLSM images (n = 3) of live/dead bacteria post treatment. Red and green fluorescence signals correspond to dead and live bacterial cells, respectively. Scale bar is 100 µm. 1 mm H2O2 are added for all experiments.

P. aeruginosa and S. aureus were then selected as the representatives of Gram‐negative and Gram‐positive ESKAPE pathogens, respectively, to investigate whether FF8 had the PTT/CDT synergistic effect to combat bacteria. First, the synergistic factor Q values (see Supporting Information for computational formula and evaluation criterion) were calculated as 1.24 and 1.23 for P. aeruginosa and S. aureus, respectively. These two Q values were larger than 1.15 which was commonly used as a cutoff indicator of “strong synergy.”[ 23 ] Second, staining with live/dead double fluorescent dyes SYTO‐9/propidium iodide (PI) and imaging with confocal laser scanning microscopy (CLSM) were carried out and the results indicated that, for either P. aeruginosa or S. aureus (Figure 2g), a few red fluorescences (dead) and abundant green fluorescence (live) were observed for bacterial cells treated with FF6, while abundant red fluorescence (dead) and a few green fluorescence (live) were observed for bacterial cells treated with FF4; by contrast, nearly all bacterial cells treated with FF8 gave red fluorescence (dead), further confirming the synergy.

Taken together, NPM123/Fc employed 1064 nm laser‐triggered photothermal effect and Fc‐dependent chemodynamic effect in a synergistic manner, achieving the excellent bactericidal efficacy against MDR ESKAPE pathogens in vitro.

2.3. Bacterial Morphological and Biochemical View of Antibacterial Mechanism In Vitro

The underlying mechanism of antibacterial action in vitro was explored with respective to bacterial morphological and biochemical changes using MDR S. aureus and P. aeruginosa as representatives by setting the abovementioned eight treatment groups (Figure  3 ). First, SEM (Figure 3a) and TEM (Figure S17, Supporting Information) was employed to observe the integrity of bacterial morphology and cell membrane after treatment: i) NPM123/Fc+NIR‐II resulted in very severe morphological wrinkling and cell membrane disruption; ii) NPM123+NIR‐II induced relatively lower levels of wrinkling and disruption; and iii) only slight wrinkling and concavity on bacterial cell surfaces was observed for the those treated with NIR‐II and no changes could be observed for those treated with the remaining 5 treatment groups. The damage to bacterial cell membrane by nanoparticles would lead to the leakage of bacterial cytoplasmic components.[ 23 ] Second, the contents of DNA, proteins, K+, and Na+ in the supernatants of P. aeruginosa (Figure 3b–e) and S. aureus (Figure 3f–i) suspensions after treatment. The results showed that the largest amounts of DNA, proteins, K+, and Na+ were detected for those treated with NPM123/Fc+NIR‐II, denoting that NPM123/Fc+NIR‐II resulted in the most severe bacterial damage. Third, CLSM (Figure 3j) was utilized to characterize DNA damage by staining bacterial DNA with 4′,6‐diamidino‐2‐phenylindole (DAPI) dye with blue fluorescence: i) only a little fluorescence intensity was observed for those treated with NPM123/Fc+NIR‐II, indicating the occurrence of most severe DNA damage; and ii) bright fluorescence could be observed for all the other treatment groups, among which the fluorescence intensity of those treated with NPM123+NIR‐II was much lower than the remaining six treatment groups. Taken together, NPM123/Fc+NIR‐II exhibited the best efficacy in damaging bacterial cell membranes (causing leakage of cytoplasmic components) and meanwhile inducing bacterial DNA damage.

Figure 3.

Figure 3

Bacterial morphological and biochemical view of antibacterial mechanism in vitro. FF1: Mock, FF2: NIR‐II, FF3: NPM123, FF4: NPM123+NIR‐II, FF5: NPFc, FF6: NPFc+NIR‐II, FF7: NPM123/Fc, FF8: NPM123/Fc+NIR‐II. NIR‐II represents 1064 nm laser irradiation (1.0 W cm−2, 3.5 min). a) SEM images of P. aeruginosa and S. aureus post treatment. Scale bar is 500 nm. Leakage of b) DNA, c) protein, d) K+, and e) Na+ by P. aeruginosa post treatment. Leakage of f) DNA, g) protein, h) K+, and i) Na+ by S. aureus post treatment. j) CLSM images of DAPI‐stained bacterial DNAs post treatment. Scale bar is 1 µm. Data are presented as mean ± SD (n = 6). ns: p ≥ 0.05, *: p < 0.05, **: p < 0.01, ***: p < 0.001. 1 mm H2O2 are added for all experiments.

2.4. Bacterial Metabolomic View of Antibacterial Mechanism In Vitro

To characterize bacterial metabolomic response after treatment in vitro, a metabolomics analysis was performed for P. aeruginosa treated with NPM123/Fc+NIR‐II in relative to Mock (Figure  4 ). First, the principal component analysis (PCA) indicated the datasets of these two groups were lasted at two different clusters, indicating the existence of obvious parallelism within each group but high‐level differences between the two groups (Figure 4a). Second, a total of 116 differentially regulated metabolites (DRMs) were identified for NPM123/Fc+NIR‐II compared Mock (Figure S18, Supporting Information), and they could be divided into 62 up‐regulated metabolites and 54 down‐regulated ones (Figure 4b,c). Third, as shown by Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis, there were the four enriched up‐regulated metabolic pathways (i.e., biosynthesis of secondary metabolites, arginine and proline metabolism, aminobenzoate degradation, and nicotinate and nicotinamide metabolism), and also the nine enriched down‐regulated metabolic pathways especially including pyrimidine metabolism, β‐alanine metabolism, alanine, aspartate and glutamate metabolism, glutathione metabolism, and purine metabolism (Figure 4d). Fourth, the major DRMs and related pathways were mapped, aiming to interpret bacterial metabolic dysregulation (Figure 4e): i) purine metabolism‐related GTP, dGMP, and deoxyguanosine were down‐regulated, thereby obstructing DNA synthesis and causing DNA damage[ 24 ]; ii) pyrimidine metabolism CMP and cytosine were down‐regulated, hence hampering RNA synthesis[ 25 ]; iii) riboflavin metabolism‐related riboflavin were up‐regulated, denoting over‐production of ROS[ 26 ]; iv) glutathione metabolism‐related putrescine and NADP+ were up‐regulated, consequently leading to enhancement of oxidative stress; and v) carbon metabolism‐related succinate and O‐acetyl‐L‐serine were down‐regulated, therefore resulting in disturbance of energy metabolism.[ 27 , 28 ] In addition, as revealed by Receiver Operating Characteristic (ROC) curve analysis (Figure S19, Supporting Information), putrescine gave an AUC (area under the ROC curve) value of 0.990 (> the cutoff 0.9[ 29 ]); therefore, the up‐regulation of putrescine (as a biomarker) denoted the pathological state in P. aeruginosa after treatment. Taken together, NPM123/Fc+NIR‐II induced inhibited nucleic acid synthesis, disordered energy metabolism, enhanced oxidative stress, and elevated DNA damage in bacteria.

Figure 4.

Figure 4

Metabolomics analysis of P. aeruginosa after treatment. a) PCA plot of clustered datasets between the two treatment groups NPM123/Fc+NIR‐II (FF8) and Mock (FF1). NIR‐II represents 1064 nm laser irradiation (1.0 W cm−2, 3.5 min). b) Volcano plot of DRMs identified for NPM123/Fc+NIR‐II compared to Mock; Up: Up‐regulated metabolites. Down: Down‐regulated metabolites. c) Heatmaps of major DRMs. d) KEGG pathway enrichment analysis of DRMs. e) Diagrams of major DRMs and related pathways. Red represents up‐regulation and blue stands for down‐regulation. Experiments were performed with five independent biological replicates. 1 mm H2O2 are added for all experiments.

2.5. Therapeutic Efficacy Against Infected Wounds in Mice

Endogenous H2O2 at infection sites would trigger the degradation of nanoparticles around infected bacteria, which would be along with the abovementioned synergistic antibacterial action under 1064 nm laser irradiation. Given this, in vivo therapeutic efficacy against infected wounds in mice was evaluated with an orderly program[ 23 ] of wound fabrication, bacterial inoculation, infection establishment, and anti‐infective therapy (Figure  5a). The infections involved two clinical MDR isolates: S. aureus USA300‐FPR3757[ 30 ] and P. aeruginosa F291007.[ 31 ] USA300‐FPR3757 belonged to the S. aureus USA300 clone, which had a highly virulent phenotype and represented a major source of community‐acquired S. aureus infections in the USA, Canada, and Europe.[ 30 ] F291007 belonged to the high‐risk P. aeruginosa ST235 clone, which displayed a hypervirulent phenotype and caused worldwide nosocomial infections with poor clinical outcomes.[ 32 ] Herein, a total of 5 therapeutic groups namely Mock, NIR‐II, NPM123, NPM123+NIR‐II, NPM123/Fc, NPM123/Fc+NIR‐II were employed. First, NPM123/Fc+NIR‐II and NPM123+NIR‐II gave almost the same tendency of temperature increase to about 48 °C within 3.5 min at P. aeruginosa‐infected wounds upon 1064 laser irradiation (Figure S20, Supporting Information). These local mild‐heat temperatures would readily cause thermal injury to bacterial cells but not surrounding tissues.[ 10 ] Second, the wounds were photographed and their areas were counted for mice infected by P. aeruginosa (Figure 5b,c) or S. aureus (Figure S21a,b, Supporting Information) at sequential time points post‐therapy; compared to all the other therapeutic groups, NPM123/Fc+NIR‐II gave the most obvious decrease in wound areas and the smoothest scabs on day 10 post‐therapy. As for body weights, there was no statistically significant difference between all five groups (Figure 5d; Figure S21c, Supporting Information). Third, the bacterial loads at wounds on day 2 post‐therapy were counted for P. aeruginosa‐ (Figure 5e,f) and S. aureus‐infected mice (Figure S21d,e, Supporting Information); NPM123/Fc+NIR‐II gave the largest inhibition rates (i.e., 94.88% and 90.98% for P. aeruginosa and S. aureus, respectively) in relative to all the other four groups. Fourth, as determined by hematoxylin and eosin (H&E) staining of wound tissues on day 10 post‐therapy for P. aeruginosa‐ (Figure 5g) and S. aureus‐infected mice (Figure S21f, Supporting Information), NPM123/Fc+NIR‐II exhibited the best histopathologic outcome—abundant fibroblasts, regenerated blood vessels, and new hair follicles in granulation tissues; by contrast, there were abundant neutrophils, macrophages, and lymphocytes at wound tissues for all the other four groups, disclosing the persistence of infection‐induced inflammation at wounds. Taken together, NPM123/Fc+NIR‐II gave the best in vivo antibacterial and wound healing efficacy.

Figure 5.

Figure 5

Therapeutic efficacy against P. aeruginosa‐infected wounds. FF1: Mock, FF2: NIR‐II, FF3: NPM123, FF4: NPM123+NIR‐II, FF7: NPM123/Fc, FF8: NPM123/Fc+NIR‐II. NIR‐II represents 1064 nm laser irradiation (1.0 W cm−2, 3.5 min). a) Schematic illustration of the orderly program of infected wound establishment and anti‐infective therapy, as well as the time points for different tests post therapy. b) Representative photos of infected wounds post therapy. Statistical analysis of c) wound areas and d) body weights post therapy. Data are presented as mean ± SD (n = 5). e) Representative photos of plate count agars for infected wounds on day 10 post‐therapy, and f) corresponding statistical analysis of bacterial load counts. Data are presented as mean ± SD (n = 6). g) Representative photos of H&E staining of infected wounds (n = 3) on day 10 post‐therapy. Scale bar is 100 µm. Black arrows denote inflammatory cells such as neutrophils, macrophages, and lymphocytes. Green arrows represent hair follicles. Yellow arrows show fibroblasts. Red arrows stand for new blood vessels. ns: p ≥ 0.05, *: p < 0.05, **: p < 0.01, ***: p < 0.001.

2.6. Host‐Response View of Anti‐Infective Mechanism In Vivo

To determine the expression of the four major proinflammatory cytokines including TNF‐α, IL‐6, IFN‐β, and IL‐17A,[ 33 , 34 ] immunohistochemistry was conducted with P. aeruginosa‐infected wound tissues on day 8 post‐therapy by Mock, NIR‐II, NPM123, NPM123+NIR‐II, NPM123/Fc, and NPM123/Fc+NIR‐II, and the results showed that the NPM123/Fc+NIR‐II resulted in the lowest production of each of these cytokines (Figure  6 ), indicating that NPM123/Fc+NIR‐II enabled the best anti‐inflammatory effect. To measure the expression of the six major wound‐healing protein factors including α‐SMA and collagen III (extracellular matrix deposition), VEGF‐A and FGF‐2 (angiogenesis), and KGF and EGF (re‐epithelialization),[ 35 , 36 ] immunofluorescence staining was carried out with P. aeruginosa‐infected wound tissues on day 8 post‐therapy by the above six therapeutic groups, and the results indicated that NPM123/Fc+NIR‐II displayed the highest production of each of these six wound‐healing factors (Figure  7 ), denoting that NPM123/Fc+NIR‐II brought the fastest wound‐healing process. Taken together, NPM123/Fc+NIR‐II exhibited the best efficacy to inhibit inflammatory reaction and meanwhile to promote wound healing.

Figure 6.

Figure 6

Immunohistochemistry assay of major proinflammatory cytokines in mice on day 8 post‐therapy. FF1: Mock, FF2: NIR‐II, FF3: NPM123, FF4: NPM123+NIR‐II, FF7: NPM123/Fc, FF8: NPM123/Fc+NIR‐II. NIR‐II represents 1064 nm laser irradiation (1.0 W cm−2, 3.5 min). (a) Representative immunohistochemical staining photos for TNF‐α, IL‐6, IFN‐β, and IL‐17A. Yellow brown represents positive detection. Scale bar = 100 µm. Corresponding statistical analysis for d) IL‐6, e) TNF‐α, f) IFN‐β, and g) IL‐17A. Data are expressed as mean ± SD (n = 3). ns: p ≥ 0.05, *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Figure 7.

Figure 7

Immunofluorescence staining assay of major wound‐healing protein factors in mice on day 8 post‐therapy. FF1: Mock, FF2: NIR‐II, FF3: NPM123, FF4: NPM123+NIR‐II, FF7: NPM123/Fc, FF8: NPM123/Fc+NIR‐II. NIR‐II represents 1064 nm laser irradiation (1.0 W cm−2, 3.5 min). Representative immunofluorescence staining photos for a) α‐SMA and Collagen III, b) VEGF‐A and FGF‐2, and c) KGF and EGF. Red represents positive detection. Scale bar = 100 µm. Corresponding statistical analysis for d) α‐SMA, e) Collagen III, g) VEGF‐A, f) FGF‐2, h) KGF, and i) EGF. Data are expressed as mean ± SD (n = 3). ns: p ≥ 0.05, *: p < 0.05, **: p < 0.01, ***: p < 0.001.

To characterize the global host response after anti‐infective therapy, RNA‐seq‐determined transcriptomes of P. aeruginosa‐infected wound tissues on day 8 post‐therapy was compared between the two therapeutic groups NPM123/Fc+NIR‐II and Mock (Figure  8 ). First, the PCA plot (Figure 8a) showed the far distance between the clustered datasets of these two groups, indicating the existence of a high‐level of data reproducibility within each group as well as a high‐degree of data differentiation between these two groups. Second, a total of 236 differentially expressed genes (DEGs) were identified for NPM123/Fc+NIR‐II in relative to Mock, and they were composed of 131 down‐regulated genes that included those encoding the above four proinflammatory cytokines, and additionally 105 up‐regulated genes that included those encoding the above six wound‐healing factors (Figure 8b). Third, as determined by gene ontology (GO) pathway enrichment analysis of these DEGs, there were the five enriched down‐regulated pathways including NF‐κB signaling, IL‐2 production, regulation of cytokine production involved in inflammatory response, negative regulation of activation‐induced cell death of T cells, and negative regulation of glucocorticoid receptor signaling pathway (Figure 8c), and meanwhile the seven enriched up‐regulated pathways including positive regulation of apoptotic process, angiogenesis, actin filament organization, positive regulation of cell differentiation, cortical cytoskeleton organization, endothelial tube morphogenesis, and regulation of hair cycle (Figure 8d). Fourth, KEGG enrichment analysis gave similar results—there were the seven enriched down‐regulated pathways including the TNF signaling pathway, NF‐κB signaling pathway, IL‐17 signaling pathway, JAK‐STAT signaling pathway, antigen processing and presentation, B cell receptor signaling pathway, leukocyte transendothelial migration (Figure 8e), and simultaneously the nine enriched up‐regulated pathways including ECM‐receptor interaction, regulation of actin cytoskeleton, adherens junction, cell adhesion molecules, VEGF signaling pathway, TGF‐β signaling pathway, Notch signaling pathway, Apelin signaling pathway, and Hippo signaling pathway (Figure 8f). Notably, all the above enriched down‐regulated pathways were involved in the resolution of excessive inflammation, while all these enriched up‐regulated pathways contributed to wound healing, giving a global view of the coordinated process of clearance of pathogenic stimuli along with restoration of tissue integrity and function. Fifth, the heatmap in Figure S22 (Supporting Information) presented not only the ten factors simultaneously revealed by the traditional immunoassay and the RNA‐seq assay, but also the 12 selected down‐regulated proinflammatory factors and the 19 selected up‐regulated wound‐healing factors additionally disclosed by RNA‐seq, all of which would be the major contributors to the highly favored therapeutic effect of NPM123/Fc+NIR‐II. Taken together, the therapeutic effect with respective to host response was mainly composed of inhibition of inflammatory reaction and meanwhile promotion of wound healing.

Figure 8.

Figure 8

RNA‐seq assay of P. aeruginosa‐infected wounds on day 8 post‐therapy. a) PCA plot of clustered datasets between the two therapeutic groups NPM123/Fc+NIR‐II (FF8) and Mock (FF1). NIR‐II represents 1064 nm laser irradiation (1.0 W cm−2, 3.5 min). b) Volcano plot of DGEs for NPM123/Fc+NIR‐II compared to Mock. Up: Up‐regulated genes. Down: Down‐regulated genes. GO pathway enrichment analysis was performed for c) down‐regulated and d) up‐regulated genes, and KEGG pathway enrichment analysis was conducted for e) down‐regulated and f) up‐regulated genes. Experiments were performed with four independent biological replicates.

2.7. Biosafety at Cellular and Animal Levels

First, the embryonic mouse normal fibroblast cell line NIH‐3T3 and the human normal ovarian epithelial cell line IOSE‐80 were used to test the potential cytotoxicity of NPM123/Fc by using Cell Counting Kit‐8 (CCK8), and each cell line gave a cell viability >80%[ 14 , 23 , 31 ] after co‐incubation with 100 µg mL−1 NPM123/Fc for 12 h (Figure S23, Supporting Information). The additional hemolysis assay with mouse red blood cells (RBCs) revealed that 100 µg mL−1 NPM123/Fc presented a hemolytic rate <5% (Figure S24, Supporting Information).[ 14 , 23 , 31 ] Second, mice with infection‐free wounds were treated with Mock, NIR‐II, NPM123, NPM123+NIR‐II, NPM123/Fc, NPM123/Fc+NIR‐II using the administration route and dosage same as anti‐infective therapy. H&E staining on day 8 post‐treatment showed no inflammatory or pathological lesions in heart, liver, spleen, lung, and kidney (Figure S25, Supporting Information). After treatment with 1 mg kg−1 lipopolysaccharide (LPS), obvious infiltration of neutrophils, macrophages, and lymphocytes were observed at wounds (positive control) but not in all the five organs (Figure S25, Supporting Information). Biochemical blood test at the same time point exhibited no abnormal changes in the two major hepatic function indexes namely alanine aminotransferase (ALT), aspartate aminotransferase (AST) and the two major renal function indexes namely blood urea nitrogen (BUN) and creatinine (CREA) (Figure S26, Supporting Information). Third, for S. aureus‐ or P. aeruginosa‐infected wounds treated with the above six groups, and H&E staining (Figure S27, Supporting Information) and biochemical blood test (Figure S28, Supporting Information) on day 8 post‐therapy gave the similar biosafety results; it should be noted that, after wounds were infected with bacteria, there was significant inflammatory reaction at infected wounds, but no obvious pathological injury was found in the heart, liver, spleen, lung, and kidney whether the therapeutic measures were applied or not. Taken together, NPM123/Fc had highly favorable biosafety at cellular and animal levels.

3. Conclusion

The present work developed a novel polymer nanomaterial NPM123/Fc for treatment of acute wound infections. We used two distinct polymers, namely the photothermal agent M123‐containing PM123 and the Fc‐containing PFc both containing ROS‐sensitive moieties, to be assemble into NPM123/Fc. Fc was built in a polymerized manner at the center locations of NPM123/Fc, and thus Fc introduced was highly controllable at high consternations. In addition, Fc as a CDT agent has been showed higher levels of biocompatibility relative to inorganic CDT metals.[ 16 , 17 , 18 ] As expected, M123 in NPM123/Fc endowed the efficient and stable photothermal effect upon 1064 nm laser irradiation and, Via Fenton‐like reaction, Fc in NPM123/Fc enabled the chemodynamic effect to produce more toxic ∙OH from endogenous H2O2 abundant at infection sites. These two distinct antibacterial contributors PTT and CDT worked in a strong synergistic manner. NPM123/Fc+NIR‐II gave >90% in vitro inhibition rates against MDR ESKAPE pathogens. The metabolomics analysis disclosed NPM123/Fc+NIR‐II in vitro induced bacterial metabolic dysregulation especially including inhibited nucleic acid synthesis, disordered energy metabolism, enhanced oxidative stress, and elevated DNA damage. NPM123/Fc+NIR‐II possessed >90% bacteriostatic rates in a mouse model of cutaneous wounds infected by P. aeruginosa and S. aureus, resulting in almost full recovery of infected wounds. The systematic immunohistochemistry, immunofluorescence staining, and transcriptomics assays with respective to host response disclosed that the therapeutic effect was mainly dependent on inhibition of inflammatory reaction and meanwhile promotion of wound healing at wound sites. The ROS‐sensitive thioketal bonds in NPM123/Fc made it degradable upon ROS. Endogenous H2O2 at infection sites would trigger the degradation of NPM123/Fc located around infected bacteria, and ∙OH generated by CDT would further promote this biodegradation. On the one hand, the rapid degradation of NPM123/Fc endowed highly favorable biosafety as observed at both cellular and animal levels. On another hand, this rapid degradation would be along with the quick release of M123 (PTT) and Fc (CDT) for subsequent rapid bactericidal actions. NPM123/Fc with a unique synergistic PTT and CDT strategy represented a biocompatible and broad‐spectrum nanoplatforms for antibiotics‐alternative treatment of acute superficial infections.

Conflict of Interest

The authors declare no conflict of interest.

Supporting information

Supporting Information

Acknowledgements

F.C. and L.L. contributed equally to this work. This work is financially supported by the National Key R&D Program of China (Grant No. 2022YFC2603900).

Chen F., Liu L., Tang D., Zhang H., Wu N., Wang L., Li H., Xiao H., Zhou D., Treatment of Acute Wound Infections by Degradable Polymer Nanoparticle with a Synergistic Photothermal and Chemodynamic Strategy. Adv. Sci. 2024, 11, 2309624. 10.1002/advs.202309624

Contributor Information

Hongbo Li, Email: hongbo_l@sina.com.

Haihua Xiao, Email: hhxiao@iccas.ac.cn.

Dongsheng Zhou, Email: zhouds@bmi.ac.cn.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  • 1. De Oliveira D. M. P., Forde B. M., Kidd T. J., Harris P. N. A., Schembri M. A., Beatson S. A., Paterson D. L., Walker M. J., Clin. Microbiol. Rev. 2020, 33, e00181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ma Y. X., Wang C. Y., Li Y. Y., Li J., Wan Q. Q., Chen J. H., Tay F. R., Niu L. N., Adv. Sci. 2019, 7, 1901872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Makabenta J. M. V., Nabawy A., Li C. H., Schmidt‐Malan S., Patel R., Rotello V. M., Nat. Rev. Microbiol. 2021, 19, 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Fan L., Idris Muhammad A., Bilyaminu Ismail B., Liu D., Ultrason. Sonochem. 2021, 75, 105591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Awad M., Thomas N., Barnes T. J., Prestidge C. A., J. Control. Release 2022, 346, 300. [DOI] [PubMed] [Google Scholar]
  • 6. Liu H., Xing F., Zhou Y., Yu P., Xu J., Luo R., Xiang Z., Rommens P. M., Liu M., Ritz U., Mater. Des. 2023, 233, 112231. [Google Scholar]
  • 7. Dediu V., Ghitman J., Gradisteanu Pircalabioru G., Chan K. H., Iliescu F. S., Iliescu C., Int. J. Mol. Sci. 2023, 24, 9375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Zhao Y., Wang Y., Wang X., Qi R., Yuan H., Nanomaterials 2023, 13, 2269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Chen Y., Gao Y., Chen Y., Liu L., Mo A., Peng Q., J. Control. Release 2020, 328, 251. [DOI] [PubMed] [Google Scholar]
  • 10. You C., Li Y., Dong Y., Ning L., Zhang Y., Yao L., Wang F., ACS Biomater. Sci. Eng. 2020, 6, 1535. [DOI] [PubMed] [Google Scholar]
  • 11. Qiu Y., Yu S., Wang Y., Xiao L., Pei L., Pu Y., Zhang Y., Biomater. Sci. 2022, 10, 1995. [DOI] [PubMed] [Google Scholar]
  • 12. Zhou K., Zhang Z., Xue J., Shang J., Ding D., Zhang W., Liu Z., Yan F., Cheng N., Int. J. Biol. Macromol. 2022, 221, 135. [DOI] [PubMed] [Google Scholar]
  • 13. Sun J., Song L., Fan Y., Tian L., Luan S., Niu S., Ren L., Ming W., Zhao J., ACS Appl. Mater. Interfaces 2019, 11, 26581. [DOI] [PubMed] [Google Scholar]
  • 14. Zhou H., Tang D., Kang X., Yuan H., Yu Y., Xiong X., Wu N., Chen F., Wang X., Xiao H., Zhou D., Adv. Sci. 2022, 9, e2200732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Jia C., Guo Y., Wu F. G., Small 2022, 18, e2103868. [DOI] [PubMed] [Google Scholar]
  • 16. Park S.‐C., Kim N.‐H., Yang W., Nah J.‐W., Jang M.‐K., Lee D., J. Controlled Release 2016, 221, 37. [DOI] [PubMed] [Google Scholar]
  • 17. Zhao X., He X., Hou A., Cheng C., Wang X., Yue Y., Wu Z., Wu H., Liu B., Li H., Inorg. Chem. 2022, 61, 9328. [DOI] [PubMed] [Google Scholar]
  • 18. Wang X., Sun X., Bu T., Wang Q., Zhang H., Jia P., Li L., Wang L., Acta Biomater. 2021, 135, 342. [DOI] [PubMed] [Google Scholar]
  • 19. He Y., Cao Y., Wang Y., Asian J. Org. Chem. 2018, 7, 2201. [Google Scholar]
  • 20. Zhang Y., Zhang S., Zhang Z., Ji L., Zhang J., Wang Q., Guo T., Ni S., Cai R., Mu X., Long W., Wang H., Front. Chem. 2021, 9, 728066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Zamojc K., Zdrowowicz M., Rudnicki‐Velasquez P. B., Krzyminski K., Zaborowski B., Niedzialkowski P., Jacewicz D., Chmurzynski L., Free Radic. Res. 2017, 51, 38. [DOI] [PubMed] [Google Scholar]
  • 22. Rane S. S., Choi P., Chem. Mater. 2005, 17, 926. [Google Scholar]
  • 23. Lu M., Li S., Xiong X., Huang Z., Xu B., Liu Y., Wu Q., Wu N., Liu H., Zhou D., Adv. Funct. Mater. 2022, 32, 2208061. [Google Scholar]
  • 24. Ba X., Aguilera‐Aguirre L., Rashid Q. T., Bacsi A., Radak Z., Sur S., Hosoki K., Hegde M. L., Boldogh I., Int. J. Mol. Sci. 2014, 15, 16975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Gkatza N. A., Castro C., Harvey R. F., Heiß M., Popis M. C., Blanco S., Bornelöv S., Sajini A. A., Gleeson J. G., Griffin J. L., West J. A., Kellner S., Willis A. E., Dietmann S., Frye M., PLoS Biol. 2019, 17, e3000297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Liang J. Y., Cheng C. W., Yu C. H., Chen L. Y., J. Photochem. Photobiol. B, Biol. 2015, 143, 82. [DOI] [PubMed] [Google Scholar]
  • 27. Adolph C., McNeil M. B., Cook G. M., mBio 2022, 13, e0167222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Franke T., Deppenmeier U., Mol. Microbiol. 2018, 109, 528. [DOI] [PubMed] [Google Scholar]
  • 29. Mandrekar J. N., J. Thorac. Oncol. 2010, 5, 1315. [DOI] [PubMed] [Google Scholar]
  • 30. Diep B. A., Gill S. R., Chang R. F., Phan T. H., Chen J. H., Davidson M. G., Lin F., Lin J., Carleton H. A., Mongodin E. F., Sensabaugh G. F., Perdreau‐Remington F., Lancet 2006, 367, 731. [DOI] [PubMed] [Google Scholar]
  • 31. Pan X., Wu N., Tian S., Guo J., Wang C., Sun Y., Huang Z., Chen F., Wu Q., Jing Y., Adv. Funct. Mater. 2022, 32, 2112145. [Google Scholar]
  • 32. Del Barrio‐Tofino E., Lopez‐Causape C., Oliver A., Int. J. Antimicrob. Agents 2020, 56, 106196. [DOI] [PubMed] [Google Scholar]
  • 33. Netea M. G., Kullberg B. J., Van der Meer J. W., BioDrugs 2004, 18, 9. [DOI] [PubMed] [Google Scholar]
  • 34. Opdal S. H., in SIDS Sudden Infant and Early Childhood Death: The Past, the Present and the Future (Eds: Duncan J. R., Byard R. W.), The University of Adelaide Press, Adelaide, Australia: 2018. [PubMed] [Google Scholar]
  • 35. Ellis S., Lin E. J., Tartar D., Curr. Derm. Rep. 2018, 7, 350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Gurtner G. C., Werner S., Barrandon Y., Longaker M. T., Nature 2008, 453, 314. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Advanced Science are provided here courtesy of Wiley

RESOURCES